Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|4|534-544

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.4, 2013-02, pp. : 534-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin D and miRNAs in Cancer

By  

Current Gene Therapy, Vol. 14, Iss. 4, 2014-01 ,pp. : 269-275

Bentham Science Publishers

Access to resources Recommend Favorite

miRNAs in Insulin Resistance and Diabetes-Associated Pancreatic Cancer: The ‘Minute and Miracle’ Molecule Moving as a Monitor in the ‘Genomic Galaxy’

By  

Current Drug Targets, Vol. 14, Iss. 10, 2013-09 ,pp. : 1110-1117

Bentham Science Publishers

Access to resources Recommend Favorite

miRNAs in breast cancer: ready for real time?

By Krell Jonathan   Frampton Adam E   Jacob Jimmy   Castellano Leandro   Stebbing Justin  

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 709-719

Future Medicine

Access to resources Recommend Favorite

miRNAs Highlights in Stem and Cancer Cells

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 13, 2011-11 ,pp. : 1165-1182

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 257-265

Bentham Science Publishers

Access to resources Recommend Favorite